TP53 mutations as a biomarker for high-grade serous ovarian cancer: Are we there yet?

Derek B. Oien, Jeremy Chien

Research output: Contribution to journalEditorialpeer-review

8 Scopus citations
Original languageEnglish (US)
Pages (from-to)S264-S268
JournalTranslational Cancer Research
StatePublished - Jan 1 2016
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this